🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Crude Oil Surges Over 2%; US Leading Economic Index Falls In December

Published 22/01/2024, 17:18
© Reuters.  Crude Oil Surges Over 2%; US Leading Economic Index Falls In December
US500
-
GILD
-
ADM
-
GC
-
SI
-
CL
-
IXIC
-
DJT
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday.

The Dow traded up 0.41% to 38,018.23 while the NASDAQ rose 0.30% to 15,356.67. The S&P 500 also rose, gaining, 0.25% to 4,851.78.

Check This Out: Top 5 Health Care Stocks That May Crash This Month

Leading and Lagging Sectors

Real estate shares rose by 0.7% on Monday.

In trading on Monday, consumer discretionary shares fell by 0.5%.

Top Headline

US leading economic index fell 0.1% for December, versus analysts’ expectations for a 0.5% decline.

Equities Trading UP

Sagimet Biosciences Inc. (NASDAQ: SGMT) shares shot up 94% to $13.24 after the company announced denifanstat in the Phase 2b FASCINATE-2 clinical trial achieved statistically significant results on the primary and multiple secondary endpoints.

Shares of Rail Vision Ltd. (NASDAQ: RVSN) got a boost, surging 69% to $2.3201. Rail Vision said its main line system has successfully obtained formal certifications for critical European Union railway standards.

Digital World Acquisition Corp. (NASDAQ: DWAC) shares were also up, gaining 26% to $33.18 after Ron DeSantis ended his presidential campaign. Digital World Acquisition Corp is the business combination partner of Trump Media & Technology Group.

Equities Trading DOWN

Virios Therapeutics, Inc. (NASDAQ: VIRI) shares dropped 40% to $0.49. Virios Therapeutics announced plans to advance development of IMC-2 as treatment for symptoms associated with long-COVID.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) were down 20% to $54.90 amid the company placing its CFO on leave due to an investigation studying accounting practices and procedures related to the company's nutrition segment. ADM said it now expects an adjusted earnings per share of $6.90 for the fiscal year ended Dec. 2023.

Gilead Sciences, Inc. (NASDAQ: GILD) was down, falling 10% to $78.98 after the company reported its phase 3 study in metastatic non-small cell lung cancer did not meet primary endpoints.

Also Check This Out: 3 Minutes To Boost Your Earnings: 3 Stocks With Over 5% Dividend Yields In Utilities Sector From Wall Street's Most Accurate Analysts

Commodities

In commodity news, oil traded up 2.3% to $75.10 while gold traded down 0.1% at $2,026.60.

Silver traded down 1.7% to $22.325 on Monday while copper fell 0.8% to $3.7570.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.82%, London’s FTSE 100 rose 0.48% while Spain’s IBEX 35 Index rose 1.15% The German DAX rose 0.70% French CAC 40 rose 0.69% while Italy’s FTSE MIB Index fell 0.27%.

Asia Pacific Markets

Asian markets closed mixed on Monday, with Japan’s Nikkei 225 gaining 1.62%, Hong Kong’s Hang Seng Index falling 2.27% and China’s Shanghai Composite Index declining 2.68%. India’s S&P BSE Sensex, meanwhile, fell 0.36%.

The annual inflation rate in Hong Kong eased to 2.4% in December from 2.6% in the prior month. The People's Bank of China kept its lending rates unchanged at the January fixing.

Economics

US leading index fell 0.1% for December, versus analysts’ expectations for a 0.5% decline.

Now Read This: How To Earn $500 A Month From AT&T Stock Ahead Of Q4 Print

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.